Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (571-580 of 6,084) with videos related to

Pageof 609
Sort By:
The Prostate|June 30, 2009
Effects of EGFR tyrosine kinase inhibitor erlotinib in prostate cancer cells in vitroClaudio Festuccia, Giovanni Luca Gravina, Leda Biordi, et al.
The Prostate|June 30, 2009
Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestryProdipto Pal, Huifeng Xi, Saurav Guha, et al.
The Prostate|July 9, 2009
A novel model of bone-metastatic prostate cancer in immunocompetent miceCarl A Power, Hnin Pwint, Jeffrey Chan, et al.
The Prostate|April 16, 2009
Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancerChunsheng Liu, Kosei Hasegawa, Stephen J Russell, et al.
The Prostate|August 12, 2009
Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+Karen S Sfanos, Tullia C Bruno, Alan K Meeker, et al.
The Prostate|January 1, 1990
Binding and functional properties of doxazosin in the human prostate adenoma and canine brainH Lepor, M Baumann, E Shapiro
The Prostate|September 3, 2009
Prohibitin regulates TGF-beta induced apoptosis as a downstream effector of Smad-dependent and -independent signalingBrian Zhu, Jianjun Zhai, Haining Zhu, et al.
The Prostate|January 1, 1990
Flutamide has no effect on adrenal androgen response to acute ACTH stimulation in patients with prostatic cancerK Carlström, A Pousette, R Stege
The Prostate|September 29, 2009
PTEN-mediated G1 cell-cycle arrest in LNCaP prostate cancer cells is associated with altered expression of cell-cycle regulatorsP W van Duijn, A C J Ziel-van der Made, J A G van der Korput, et al.
The Prostate|October 1, 2009
Tumor suppressor PAX6 functions as androgen receptor co-repressor to inhibit prostate cancer growthChih-Rong Shyr, Meng-Yin Tsai, Shuyuan Yeh, et al.
Pageof 609

Showing results (571-580 of 6,084) with videos related to

Sort By:
Pageof 609
The Prostate|June 30, 2009
Effects of EGFR tyrosine kinase inhibitor erlotinib in prostate cancer cells in vitroClaudio Festuccia, Giovanni Luca Gravina, Leda Biordi, et al.
The Prostate|June 30, 2009
Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestryProdipto Pal, Huifeng Xi, Saurav Guha, et al.
The Prostate|July 9, 2009
A novel model of bone-metastatic prostate cancer in immunocompetent miceCarl A Power, Hnin Pwint, Jeffrey Chan, et al.
The Prostate|April 16, 2009
Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancerChunsheng Liu, Kosei Hasegawa, Stephen J Russell, et al.
The Prostate|August 12, 2009
Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+Karen S Sfanos, Tullia C Bruno, Alan K Meeker, et al.
The Prostate|January 1, 1990
Binding and functional properties of doxazosin in the human prostate adenoma and canine brainH Lepor, M Baumann, E Shapiro
The Prostate|September 3, 2009
Prohibitin regulates TGF-beta induced apoptosis as a downstream effector of Smad-dependent and -independent signalingBrian Zhu, Jianjun Zhai, Haining Zhu, et al.
The Prostate|January 1, 1990
Flutamide has no effect on adrenal androgen response to acute ACTH stimulation in patients with prostatic cancerK Carlström, A Pousette, R Stege
The Prostate|September 29, 2009
PTEN-mediated G1 cell-cycle arrest in LNCaP prostate cancer cells is associated with altered expression of cell-cycle regulatorsP W van Duijn, A C J Ziel-van der Made, J A G van der Korput, et al.
The Prostate|October 1, 2009
Tumor suppressor PAX6 functions as androgen receptor co-repressor to inhibit prostate cancer growthChih-Rong Shyr, Meng-Yin Tsai, Shuyuan Yeh, et al.
Pageof 609